Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Kyoko, Takashima"'
Autor:
Haruka Nakada, Saori Watanabe, Kyoko Takashima, Shohei Suzuki, Yuki Kawamura, Yutori Takai, Kenji Matsui, Keiichiro Yamamoto
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 18, Iss 1, Pp 1-12 (2023)
Abstract Background Rare diseases (RDs) may impose a considerable financial burden on patients and their families. Public acceptance is essential to ensure sustainable public systems supporting RDs, especially in countries with universal healthcare c
Externí odkaz:
https://doaj.org/article/6bbd61499bf4450aaaad5b8d945ec9da
Publikováno v:
BMC Medical Ethics, Vol 19, Iss 1, Pp 1-6 (2018)
Abstract Background Platforms for sharing genomic and phenotype data have been developed to promote genomic research, while maximizing the utility of existing datasets and minimizing the burden on participants. The value of genomic analysis of trios
Externí odkaz:
https://doaj.org/article/04bfb84881684301af9a3e14ae892e04
Publikováno v:
The American Journal of Bioethics. 23:119-121
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::231e5a292a6dbd3a6fb640d1ccedf56d
https://doi.org/10.1080/15265161.2023.2191038
https://doi.org/10.1080/15265161.2023.2191038
Publikováno v:
TransNav: International Journal on Marine Navigation and Safety of Sea Transportation, Vol 11, Iss 4, Pp 705-710 (2017)
In this paper, we present a concept of an application of UAV drones as a possible low-cost device to avoid pirate attacks. Recent UAV drone can be operated in the range of more than 2km and transmit very clear images. Pirates will be approaching usin
Externí odkaz:
https://doaj.org/article/af7cd19b25044c25b9d04f7f0a5a2721
Publikováno v:
Environmental Health and Preventive Medicine, Vol 22, Iss 1, Pp 1-7 (2017)
Abstract Objective This article provides a comprehensive review of the healthcare reform process driven by the Vietnamese Ministry of Health’s Direction of Healthcare Activities (DOHA) scheme. Methods We reviewed policy documents relating to DOHA,
Externí odkaz:
https://doaj.org/article/0b326029a5af4f5f9d3cfb99fdd309ab
Publikováno v:
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 53:147-154
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c08a9ce8506db189bbe7ddb708a02de4
https://doi.org/10.3999/jscpt.53.4_147
https://doi.org/10.3999/jscpt.53.4_147
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Haruka Nakada, Kyoko Takashima, Yuichi Maru, Tsunakuni Ikka, Koichiro Yuji, Sachie Yoshida, Kenji Matsui
Publikováno v:
Asian bioethics review. 14(3)
Improving public understanding and acceptance are critical for promoting coronavirus (COVID-19) vaccination. However, how to promote COVID-19 vaccine programs remains controversial due to various ethical issues. This study, thus, aimed to survey the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12ecc0cc78979f13abc9e9df9e3dfd02
https://pubmed.ncbi.nlm.nih.gov/35573157
https://pubmed.ncbi.nlm.nih.gov/35573157
Autor:
Kyoko Takashima, Haruka Nakada
Publikováno v:
Clinical Pharmacology in Drug Development
Investigational treatments are those that have been approved for testing in humans but are not yet available as an approved treatment option. For many patients with a terminal illness who have no approved treatment option and are not eligible for a c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b04ae5f1d2412422662928599444a523
https://doi.org/10.1002/cpdd.745
https://doi.org/10.1002/cpdd.745
Comparative Assessment of Non-trial Access to Investigational Medical Products in the U.S. and Japan
Publikováno v:
Therapeutic innovationregulatory science. 55(2)
The U.S. and Japan have preapproval access systems for patients who have exhausted approved treatment options. We compare the systems of both countries and discuss some ethical concerns surrounding non-trial access to investigational drugs. Notable p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ec0002646d99567d07f077757047585
https://pubmed.ncbi.nlm.nih.gov/33098080
https://pubmed.ncbi.nlm.nih.gov/33098080